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Introduction. This study aims to estimate the Socio-Economic 
Status (SES) inequality on the metastasis, recurrence, stage and 
grade in Breast Cancer (BC). 
Methods. This retrospective cohort study conducted on 411 BC 
patients in Arak, Iran. Asset-based questionnaire used to estimate 
the household SES. For calculate of SES inequality was used from 
Concentration Index (C). Moreover for investigate the association 
between recurrence and metastasis with other variables were 
used from multilevel logistic regression and analysis of variance 
were used to investigate the relationship between SES and other 
variables. The data were analyzed with Stata (v.13) software. 
Results. Results of analysis of variance showed statistical significant 
relationship between SES with, insurance, surgery, grade, stage, 
recurrence and metastasis (p-value  <  0.05). Moreover the Odds 
Ratio (OR) were significant of recurrence with age, academic level 
of education, supplementary insurance history of BC in first-degree 
relatives, stage and grade, also, metastasis with age of > 80 years, 
insurance, supplementary insurance, history of BC in first-degree 
relatives, chemotherapy, radiotherapy, stage and grade four. The 
total C index obtained 0.015 (0.002, 0.026), 0.011 (0.003, 0.031), 
–  0.014 (–  0.034, –  0.001) and – 0.042 (–  0.061, –  0.002) for 
metastasis, recurrence, stage and grade of BC respectively.
Conclusions. Our results showed evidence of inequality in the 
metastasis, recurrence, stage and grade in BC patients.
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Introduction
Breast cancer (BC) accounts for about one-third of 
all cancers in women. This cancer is the second most 
common cancer after lung cancer and the most common 
cause of cancer deaths among women [1]. 
BC with nearly 1.7 million cases was considered as 
the most prevalent cancer among women in 2016  [2]. 
Breast cancer has led to 535,000 deaths and 15.1 million 
DALYs [2]. The incidence and mortality rate of BC has 
increased in recent years in Asian countries as well as 
Iran [2-4]. 
Some factors such as age, estrogen receptor status 
and lymph node involvement as factors influencing 
recurrence [5]. One of the most important problems in 
this cancer was the metastasis of cancer cells to other 
organs, which was, in fact, one of the main causes of 
failure in the treatment  [6]. The metastasis was seen 
among the 5-10% of patients  [7]. Also, the factors 
affecting the metastasis was identified, such as the 
initial size of the tumor, lymph node involvement, 
disease grade, estrogen receptor status, and the interval 
between surgery, and local recurrence  [8]. Moreover, 
the tumor stage, access to health-care services, 
comorbidity, cigarette smoking, Body Mass Index 
(BMI), stress, and social support were associated with 
the prognosis and the risk of death of BC. The SES 
was related to hormone therapy, smoking, and access 
to health-care and affects metastasis, recurrence, 
stage, and grade of diagnosis  [9]. The SES and the 
level of education lead to a difference in the stage 
and subsequently survival of BC  [10,  11]. Early 
diagnosis with treatment was an appropriate strategy 
for improving prognosis. Population-based screening 
programs reduce the incidence and death of cancer, due 
to extensive population coverage and improved follow-
up and control. The SES was referred to socio-economic 
factors such as education level, income and occupation, 
which can affect a person’s or group’s situation in the 
community [12]. However, the role of SES inequality 
in outcomes of BC cancer remains uncertain. 
Despite the many efforts in different periods to reduce 
the difference between the poor and the rich, through 
the redistribution of wealth to create an equal society, 
social inequalities have not disappeared and even seems 
increased globally. Health inequality is one of the most 
important indexes of inequality. It has been shown in 
various studies, that the overall incidence and mortality 
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rates in poorer economic groups are higher, due to an 
increase in inequality index in particular areas [13]. The 
relation between inequality and health is an important 
issue. Inequality is an issue at the social level that 
imposes a lot of costs on society. Health is one of the 
most important indicators of human capital. Therefore, 
inequality has the greatest effect on health [14]. Income 
inequality affects people’s health in many ways. The 
high level of inequality undermines social capital, also, 
caused stress among individuals in the community, 
which set these behaviors affects general health  [15]. 
At the individual level, the person’s income increases 
the health, but community-based studies do not endorse 
this theory. Because there are countries that, although 
lower income than high-income countries have high 
health status, because they have less inequality  [16]. 
The BC is curable and also can be prevented with early 
detection and if does not metastasize to other tissues. 
Achieving health care and screening services can lead 
to early diagnosis and prevention of disease severity. 
SES inequality can also play an important role in 
people’s health. To date, no study has been performed 
yet, that can identify the role of SES inequality in 
recurrence, metastasis, grade and stage of BC. This gap 
was addressed in this study.
Methods
Study design and sampling 
This retrospective cohort study conducted on 411 BC 
patients referred to hospitals of Arak University of 
Medical Sciences. The sampling method is accessible 
(non-randomized). In this study, we analyzed all cases 
during the study period.
Instrument
Two questionnaires were used to data collection in this 
study: 1) the demographic and disease information 
questionnaire includes age, marital status, education, 
job, insurance, supplementary insurance, history 
of BC in first-degree relatives, chemotherapy, 
radiotherapy, surgery, stage and grade of BC patients; 
2) a questionnaire designed by Gorramoodi et al. 
was used to measure the SES. This questionnaire 
includes questions about the level of women’s 
education, the education of her husband, the area of 
the infrastructure, the cost of home, the number of 
rooms and the facilities and amenities (personal car, 
personal computer, more than one TV, refrigerator, 
washing machine, dishwasher, mobile phone and 
traveling abroad. The correlation of these factors with 
a score reliability was obtained 0.87 and validity was 
obtained 0.88 respectively [17].
Statistical analysis
To investigate the relationship between recurrence 
and metastasis with other variables, binary logistic 
regression was used because these two variables were 
dichotomous. Using this method, the OR for each 
variable is calculated with constant considering effect 
of other variables. Moreover to evaluate the relationship 
between SES with other variables, analysis of variance 
was used. All statistical analyzes were performed using 
Stata (v.13) software.
Measurement of SES and Inequality
In this study, a new variable was created as an SES, 
using the Principal Component Analysis (PCA) 
method. The PCA method identifies the variables that 
have the greatest effect on the variance of the total 
variables, and then constructs the new variable. The 
first component derived from the analysis, explains 
the most variance in the variables and gives each 
family a score that is considered as an indicator of its 
SES [18, 19].
The Concentration index (C) was used to determine 
the inequality in this study. The value of this index 
varies between + 1 to – 1. When the line of equality 
and the C curve fit together, the C index will be zero, 
which means that there is no inequality. The C index 
is defined by the area under the C curve multiplication 
in two. With the greater interval between the C curve 
of the inequality line the amount of inequality also 
increases. When the C curve is above the equality line, 
the C index will be negative, which means that, the 
concentration of the investigated factor (in this study: 
metastasis, recurrence, stage and grade of BC is more 
in lower SES. Also when the C curve is under the 
equality line, the C index will be positive, which means 
that the concentration of the investigated factor is more 
in highest SES [20, 21]. 
The C index is a common inequity measure in health 
outcomes and has been used continually in recent 
studies [20, 22]. The C was calculated by the Kakwani 
et al. formula [20] (formula 1).
In this formula, µ is the mean in studied patients with 
cancer and µt is that for the tth group. In addition, ft, is 
the group share of patients. Also, Rt, is the relative rank 
of the tth educational level of the participating patients, 
which was obtained through formula 2:
Therefore, Rt indicates the cumulative proportion 
up to the midpoint of each SES group interval. The 
correspondence confidence interval for C is calculated 
based on Wagstaff and Van Doorslaer method [20, 23]. 
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This method has been used in other studies [24-29] and 
is as given below.
In this formula is the variance of µt,
and ,which 
is the ordinate of L (P), q0 = 0 and 
Results 
In total, 411 women with mean age of 20-87 participated 
in this study. Mean score of SES was 0.29 ± 0.94 (– 2.71, 
2.2). Of all patients, 19.7% had a good SES, 71.04% had 
a middle and 9.26% had a poor SES. 
The crude and adjusted OR of relationship between the 
recurrence and other variables showed in Table I. According 
to these results, the OR was significant for relationship 
between recurrence and supplementary insurance, history 
of radiotherapy, stage 4 and grade 3 of BC patients. 
The crude and adjusted OR of relationship between 
the metastasis and other variables showed in Table  II. 
According to these results, the OR was significant 
for relationship between the metastasis and history of 
surgery, stage 4, grade 2, and grade 3 of BC patients. 
Differences in mean of subgroups of variables in this 
study by SES showed in Table III. These results shown 
significant relationship between SES with supplementary 
insurance and grade of BC (p-value < 0.05).
C index obtained –  0.0025 (–  0.0153, 0.0103) and 
–  0.00001 (–  0.01623, 0.01620) for recurrence and 
metastasis respectively. Also for stage and grade of BC, 
C index obtained 0.0013 (-0.009, 0.011) and –  0.004 
(– 0.0145, 0.0059) respectively, that showed there was not 
concentration of metastasis, recurrence, stage and grade 
by SES levels (Tab. IV). In addition, the concentration 
curve for recurrence and metastasis showed that there 
was no concentration of these outcomes by SES level 
(Figs. 1, 2).
Tab. I. The crude and adjusted OR of recurrence with other variables.
Variables Subgroups Crude Adjusted*
OR (95% CI) OR (95% CI)
Age
< 40
40-60
> 60
Reference
2.91 (0.36, 23.27)
3.54 (0.43, 28.94)
Reference
4.28 (0.48, 37.84)
2.91 (0.26, 32.25)
Marital status
Single
Married
Widow/divorced
Reference
1.65 (0.20, 13.65)
0.94 (0.09, 9.53)
Reference
2.29 (0.26, 19.71)
1.39 (0.12, 15.60)
Education
Illiterate
Primary
Diploma
Academic
Reference
0.33 (0.12, 0.87)
0.85 (0.31, 2.32)
0.27 (0.05, 1.27)
Reference
0.27 (0.08, 0.89)
1.06 (0.3, 3.71)
0.43 (0.05, 3.69)
Job
Housewife
Retired
Unemployment
Permanent/temporary
Reference
0.31 (0.04, 2.45)
2.26 (0.41, 12.28)
0.75 (0.16, 3.49)
Reference
0.28 (0.02, 2.81)
2.73 (0.44, 16.81)
1.14 (0.18, 7.29)
Insurance
No
Yes
Reference
0.48 (0.04, 4.80)
Reference
0.43 (0.02, 6.69)
Supplementary insurance
No
Yes
Reference
2.19 (1.00, 4.77)
Reference
2.94 (1.21, 7.14)
History of BC in first-degree relatives
No
Yes
Reference
1.43 (0.66, 3.13)
Reference
1.12 (0.47, 2.68)
Chemotherapy
No
Yes
Reference
2.91 (0.98, 8.71)
Reference
2.67 (0.82, 8.61)
Radiotherapy
No
Yes
Reference
2.42 (1.12, 5.24)
Reference
2.73 (1.17, 6.34)
Surgery
No
Yes
Reference
0.32 (0.13, 0.78)
Reference
0.38 (0.14, 1.05)
Stage
One
Two
Three
Four
Reference
0.17 (0.01, 3.00)
1.04 (0.12, 9.02)
27.5 (3.03, 249.48)
Reference
0.15 (0.001, 2.99)
1.09 (0.10, 10.86)
49.24 (4.06, 596.2)
Grade
One
Two 
Three
Reference
3.42 (0.91, 12.77)
9.47 (2.52, 35.59)
Reference
2.93 (0.75, 11.44)
9.43 (2.34, 38.06)
*: adjusted for age, marital status, education level, and job.
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Discussion
The results of our study showed that most patients 
were housewives, also were in middle level of SES. 
Moreover the most of patients had a primary level of 
education. In a study, most of the patients, had a under 
diploma level of education. In evaluating the status 
of employment, the results showed that most of the 
patients were housewives and other were employed, 
also had a middle level of income, which is consistent 
with our study result [30].
The results of this study showed that there was no the 
significant relationship between the metastasis and 
Tab. II. The crude and adjusted OR of metastasis with other variables.
Variables Subgroups Crude Adjusted*
OR (95% CI) OR (95% CI)
Age
< 40
40-60
> 60
Reference
1.29 (0.45, 3.67)
1.32 (0.44, 3.91)
Reference
1.91 (0.59, 6.15)
2.07 (0.53, 8.06)
Marital status
Single
Married
Widow/divorced
Reference
0.68 (0.20, 2.30)
0.57 (0.14, 2.26)
Reference
0.73 (0.20, 2.61)
0.58 (0.13, 2.46)
Education
Illiterate
Primary
Diploma
Academic
Reference
0.77 (0.39, 1.52)
0.80 (0.34, 1.90)
1.03 (0.44, 2.40)
Reference
0.83 (0.37, 1.86)
1.06 (0.39, 2.84)
2.31 (0.68, 7.86)
Job
Housewife
Retired
Unemployment
Permanent/temporary
Reference
0.68 (0.22, 2.11)
1.85 (0.42, 8.02)
0.65 (0.21, 1.99)
Reference
0.42 (0.11, 1.62)
1.82 (0.39, 8.39)
0.44 (0.12, 1.58)
Insurance
No
Yes
Reference
0.39 (0.08, 1.80)
Reference
0.29 (0.05, 1.63)
Supplementary insurance
No
Yes
Reference
1.38 (0.79, 2.43)
Reference
1.52 (0.81, 2.86)
History of BC in first-degree 
relatives
No
Yes
Reference
0.99 (0.57, 1.74)
Reference
0.90 (0.50, 1.64)
Chemotherapy
No
Yes
Reference
1.07 (0.57, 2.01)
Reference
0.95 (0.48, 1.88)
Radiotherapy
No
Yes
Reference
1.06 (0.60, 1.88)
Reference
1.14 (0.62, 2.07)
Surgery
No
Yes
Reference
0.38 (0.19, 0.78)
Reference
0.35 (0.16, 0.76)
Stage
One 
Two 
Three 
Four 
Reference
1.10 (0.76, 3.23)
1.87 (0.65, 4.56)
9.72 (2.11, 73.21)
Reference
0.91 (0.05, 8.41)
1.92 (0.23, 8.42)
11.28 (3.56, 45.12)
Grade
One 
Two 
Three 
Reference
4.02 (1.67, 9.65)
8.27 (3.18, 21.50)
Reference
3.91 (1.58, 9.62)
9.24 (3.35, 25.44)
*: adjusted for age, marital status, education level, and job.
Tab. III. Relationship between SES and other variables.
Characteristics Subgroups Mean SD P-value
Insurance
No
Yes
– 0.46
0.04
1.08
0.93
0.055
Supplementary 
insurance
No
Yes
– 0.08
0.16
0.91
0.95
0.006*
Chemotherapy 
No
Yes
– 0.058
0.079
0.89
0.96
0.160
Radiotherapy 
No
Yes
0.05
– 0.02
0.96
0.90
0.421
Surgery 
No
Yes
-0.032
0.042
0.87
0.95
0.578
Grade
One
Two
Three
Four
– 0.1
0.063
0.094
0.022
0.84
0.93
0.89
0.49
0.011*
Stage
One
Two
Three
Four
0.16
– 0.12
0.30
– 0.50
0.65
0.99
0.85
0.95
0.865
Recurrence
No
Yes
0.02
0.04
0.90
0.72
0.926
Metastasis
No
Yes
0.07
0.04
0.88
0.93
0.785
*: significant.
Tab. IV. Calculation of C indexes and their 95% CI, for metastasis, 
recurrence, stage and grade of BC patients.
Outcomes Concentration
index
95% Confidence 
intervals
Recurrence – 0.0025 – 0.0153, 0.0103
Metastasis – 0.00001 – 0.01623, 0.01620
Stage 0.0013 – 0.009, 0.011
Grade – 0.004 – 0.0145, 0.0059
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recurrence of BC with age of patients. In some studies, 
it has been concluded that metastasis occurs at an earlier 
age, which is not consistent with our findings  [31]. 
In some studies the role of age has proven to be an 
important factor in causing a bad prognosis in patients 
with a variety of cancers  [32]. Results of Bennier’s 
study in French showed the probability of recurrence 
and metastasis of BC was higher in patients older than 
35 years. Also shown that patients with age of 35 years, 
before menopause had a better prognosis than the first 
group and patients over 60 years of age had a worse 
prognosis than the second group [33].
In our study, there was no the significant relationship 
between education levels with metastasis and 
recurrence. In various studies, appropriate prevention 
and treatment of BC have relationship with education. 
Also, there is a significant relationship between 
knowledge of risk factors for BC and the level of 
education, which this knowledge can prevent the 
metastasis and recurrence  [34]. Our results showed 
that there was a significant relationship between the 
existences of supplementary insurance in patients with 
recurrence. In other words, the recurrence in patients 
with supplementary insurance was occurred more than 
other patients. Having supplementary insurance helps 
to encourage individuals for treatment and screening 
and causes more diagnosis and sooner discovering 
the disease. Therefore, it can be concluded that 
SES directly affect the stage, grade, recurrence and 
metastasis of BC [35]. Also, in a study, the insurance 
status had an important role in the outcomes of BC, 
even with adjusting for SES [36].
Some studies had identified a number of genes that 
causes metastasis in various tissues in BC  [37]. 
However, there was not association between history 
of BC in first degree relatives with recurrence and 
metastasis. Cancer patients receive different therapies 
after surgery that can affect the survival, recurrence 
and metastasis [38]. In our study, the effect of surgery 
on metastasis was evident. In some studies, the role of 
radiotherapy has been shown to reduce metastasis [39]. 
Also results of our study showed grade and stage of 
BC had a relationship with recurrence and metastasis. 
Other studies showed a significant correlation between 
tumor size with recurrence and metastasis also with 
staging of BC [40].
The C index for health expenditure has always been 
positive, stating that health costs in higher deciles is 
Fig. 1. Concentration Curve of SES inequality in recurrence.
Fig. 2. Concentration Curve of SES inequality in metastasis.
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higher than lower deciles. This can be due to the low 
pay ability of low income deciles or lack of access to 
health services. The C index is closer to zero, indicating 
a more equality concentration on health costs among 
different deciles. The C index was 0.498 at 2009 in 
Iran, which indicates significant inequalities in health 
costs. An increase in inequality could be affected by 
rising prices due to economic policies or discriminatory 
health policies. An increase in inequality, can have a 
more negative effect on the health expenditure of lower 
SES groups [41]. According to the results of this study, 
there was not SES inequality in recurrence, metastasis, 
stage and grade of BC. This was the first study in this 
field. Although the role of SES inequality in health 
has been evaluated in some studies  [42-45]. In some 
studies, the effect of SES on the incidence of cancer is 
reversed. For example in a study by Tweed et al., BC 
had a low incidence in areas with lower SES [46]. In a 
study in European countries the role of SES inequality 
evaluated in health. The C index varied from 0.0034 in 
the Netherlands to 0.0218 in Portugal. Also in this study 
patients with high SES are more likely to use diagnostic 
and therapeutic test, which leads to early detection of the 
disease [47]. 
Conclusions 
BC is the most common cancer among women. Many 
complications of this cancer can be prevented with 
early detection. To date no study has been performed 
that evaluate the role of SES inequity in recurrence, 
metastasis, grade, and stage of BC. Therefore, our 
study results can be good evident of the importance 
of this topic. Due to the important role of SES and the 
existence of insurance and supplementary insurance, 
in early detection and treatment of BC, it is suggested 
that measures be taken to allow BC diagnostic and 
screening services to be available at a lower cost to the 
public. Also, with the reduction of SES inequality and 
increase in screening test, BC can be detected earlier and 
metastasis and recurrence decrease eventually. 
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